FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3160258002> ?p ?o ?g. }

• W3160258002 abstract "There is limited and discordant evidence on the role of nicotine in diabetic vascular disease. Exacerbated endothelial cell dysregulation in smokers with diabetes is associated with the disrupted adipose function. Adipokines possess vascular protective, anti-inflammatory, and anti-diabetic properties. However, whether and how nicotine primes and aggravates diabetic vascular disorders remain uncertain. In this study, we evaluated the alteration of adiponectin (APN) level in high-fat diet (HFD) mice with nicotine (NIC) administration. The vascular pathophysiological response was evaluated with vascular ring assay. Confocal and co-immunoprecipitation analysis were applied to identify the signal interaction and transduction. These results indicated that the circulating APN level in nicotine-administrated diabetic Apolipoprotein E-deficient (ApoE-/-) mice was elevated in advance of 2 weeks of diabetic ApoE-/- mice. NIC and NIC addition in HFD groups (NIC + HFD) reduced the vascular relaxation and signaling response to APN at 6 weeks. Mechanistically, APN receptor 1 (AdipoR1) level was decreased in NIC and further significantly reduced in NIC + HFD group at 6 weeks, while elevated suppressor of cytokine signaling 3 (SOCS3) expression was induced by NIC and further augmented in NIC + HFD group. Additionally, nicotine provoked SOCS3, degraded AdipoR1, and attenuated APN-activated ERK1/2 in the presence of high glucose and high lipid (HG/HL) in human umbilical vein endothelial cells (HUVECs). MG132 (proteasome inhibitor) administration manifested that AdipoR1 was ubiquitinated, while inhibited SOCS3 rescued the reduced AdipoR1. In summary, this study demonstrated for the first time that nicotine primed vascular APN resistance via SOCS3-mediated degradation of ubiquitinated AdipoR1, accelerating diabetic endothelial dysfunction. This discovery provides a potential therapeutic target for preventing nicotine-accelerated diabetic vascular dysfunction." @default.
• W3160258002 created "2021-05-24" @default.
• W3160258002 creator A5005555777 @default.
• W3160258002 creator A5009679536 @default.
• W3160258002 creator A5013484301 @default.
• W3160258002 creator A5016881573 @default.
• W3160258002 creator A5023846560 @default.
• W3160258002 creator A5025127938 @default.
• W3160258002 creator A5029871226 @default.
• W3160258002 creator A5035282947 @default.
• W3160258002 creator A5037677450 @default.
• W3160258002 creator A5037993198 @default.
• W3160258002 creator A5055360140 @default.
• W3160258002 creator A5057417740 @default.
• W3160258002 creator A5062169275 @default.
• W3160258002 creator A5066067489 @default.
• W3160258002 creator A5070812231 @default.
• W3160258002 creator A5077581291 @default.
• W3160258002 date "2021-05-18" @default.
• W3160258002 modified "2023-10-09" @default.
• W3160258002 title "Nicotine aggravates vascular adiponectin resistance via ubiquitin-mediated adiponectin receptor degradation in diabetic Apolipoprotein E knockout mouse" @default.
• W3160258002 cites W1846289750 @default.
• W3160258002 cites W1966947819 @default.
• W3160258002 cites W1978359426 @default.
• W3160258002 cites W1989271455 @default.
• W3160258002 cites W1991572864 @default.
• W3160258002 cites W1996189760 @default.
• W3160258002 cites W1997978122 @default.
• W3160258002 cites W2017918734 @default.
• W3160258002 cites W2024636345 @default.
• W3160258002 cites W2030604230 @default.
• W3160258002 cites W2037001017 @default.
• W3160258002 cites W2039357052 @default.
• W3160258002 cites W2061820469 @default.
• W3160258002 cites W2063937332 @default.
• W3160258002 cites W2090193692 @default.
• W3160258002 cites W2103552916 @default.
• W3160258002 cites W2109427581 @default.
• W3160258002 cites W2113048216 @default.
• W3160258002 cites W2139021014 @default.
• W3160258002 cites W2143041174 @default.
• W3160258002 cites W2144912947 @default.
• W3160258002 cites W2287859856 @default.
• W3160258002 cites W2297988891 @default.
• W3160258002 cites W2317697405 @default.
• W3160258002 cites W2588405995 @default.
• W3160258002 cites W2597766308 @default.
• W3160258002 cites W2610348712 @default.
• W3160258002 cites W2740389621 @default.
• W3160258002 cites W2747050788 @default.
• W3160258002 cites W2765307661 @default.
• W3160258002 cites W2791317271 @default.
• W3160258002 cites W2801903938 @default.
• W3160258002 cites W2895752892 @default.
• W3160258002 cites W2920860532 @default.
• W3160258002 cites W2921173279 @default.
• W3160258002 cites W2943463805 @default.
• W3160258002 cites W2949952454 @default.
• W3160258002 cites W3006078229 @default.
• W3160258002 cites W3083050368 @default.
• W3160258002 cites W3101019740 @default.
• W3160258002 cites W4210757594 @default.
• W3160258002 cites W4376595339 @default.
• W3160258002 doi "https://doi.org/10.1038/s41419-021-03772-y" @default.
• W3160258002 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8131622" @default.
• W3160258002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34006831" @default.
• W3160258002 hasPublicationYear "2021" @default.
• W3160258002 type Work @default.
• W3160258002 sameAs 3160258002 @default.
• W3160258002 citedByCount "3" @default.
• W3160258002 countsByYear W31602580022022 @default.
• W3160258002 countsByYear W31602580022023 @default.
• W3160258002 crossrefType "journal-article" @default.
• W3160258002 hasAuthorship W3160258002A5005555777 @default.
• W3160258002 hasAuthorship W3160258002A5009679536 @default.
• W3160258002 hasAuthorship W3160258002A5013484301 @default.
• W3160258002 hasAuthorship W3160258002A5016881573 @default.
• W3160258002 hasAuthorship W3160258002A5023846560 @default.
• W3160258002 hasAuthorship W3160258002A5025127938 @default.
• W3160258002 hasAuthorship W3160258002A5029871226 @default.
• W3160258002 hasAuthorship W3160258002A5035282947 @default.
• W3160258002 hasAuthorship W3160258002A5037677450 @default.
• W3160258002 hasAuthorship W3160258002A5037993198 @default.
• W3160258002 hasAuthorship W3160258002A5055360140 @default.
• W3160258002 hasAuthorship W3160258002A5057417740 @default.
• W3160258002 hasAuthorship W3160258002A5062169275 @default.
• W3160258002 hasAuthorship W3160258002A5066067489 @default.
• W3160258002 hasAuthorship W3160258002A5070812231 @default.
• W3160258002 hasAuthorship W3160258002A5077581291 @default.
• W3160258002 hasBestOaLocation W31602580021 @default.
• W3160258002 hasConcept C121608353 @default.
• W3160258002 hasConcept C126042315 @default.
• W3160258002 hasConcept C126322002 @default.
• W3160258002 hasConcept C134018914 @default.
• W3160258002 hasConcept C179185449 @default.
• W3160258002 hasConcept C2776782570 @default.
• W3160258002 hasConcept C2777391703 @default.
• W3160258002 hasConcept C2779183219 @default.
• W3160258002 hasConcept C2779547902 @default.
• W3160258002 hasConcept C555293320 @default.

• next